Evaluation of oxidative stress biomarkers in patients with chronic renal failure: a case control study by Romeu, Marta et al.
SHORT REPORT Open Access
Evaluation of oxidative stress biomarkers in
patients with chronic renal failure: a case control
study
Marta Romeu
1, Rosa Nogues
1, Luís Marcas
2, Vanesa Sánchez-Martos
1, Miquel Mulero
3, Alberto Martinez-Vea
2,
Jordi Mallol
1, Montserrat Giralt
1*
Abstract
Background: Oxidative stress is related to several diseases, including chronic renal insufficiency. The disequilibrium
in the oxidant-antioxidant balance is the result of several metabolic changes. The majority of studies to-date have
evaluated the grade of oxidative stress with a single biomarker, or a very limited number of them.
Findings: The present study used several important biomarkers to establish a score relating to oxidative stress
status (glutathione S-transferase, superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase,
reduced and oxidized glutathione, thiobarbituric acid reactive substances and hemolysis test). The score of
oxidative stress (SOS) was then applied to a group of patients with renal insufficiency not on hemodialysis, and
compared to healthy control individuals.
The score for patients with chronic renal insufficiency was significantly different from that of the healthy control
group (0.62 ± 1.41 vs. -0.05 ± 0.94; p < 0.001). The comparison between patients with chronic renal insufficiency
and control individuals showed significant differences with respect to changes in the enzymatic antioxidant sys-
tems (glutathione S-transferase, glutathione reductase), non-enzymatic antioxidant system (oxidized glutathione)
and oxidizability (hemolysis test) indicating significant oxidative stress associated with chronic renal insufficiency.
Conclusions: Patients with chronic renal insufficiency not on hemodialysis are susceptible to oxidative stress. The
mechanisms that underlie this status are the consequence of changes in glutathione and related enzymes. The
SOS scoring system is a useful biochemical parameter to evaluate the influence of oxidative stress on the clinical
status of these patients.
Findings
Healthy individuals cope with free radicals in the biolo-
gical system using their own anti-radical “mop-up” sys-
tems which quench reactive oxygen species (ROS),
scavenge damaged molecules, and repair molecular inju-
ries [1].
There is considerable disequilibrium between oxidants
and anti-oxidants in patients with chronic renal insuffi-
ciency (CRI). Evidence suggests that ROS are not merely
the consequence of treatment or progress of the disease
but one of the causal agents of CRI, and that oxidative
stress (OS) can take place even in the absence of
hemodialysis. Patients withu r e m i ah a v ed i m i n i s h e d
response to OS due, probably, to a decrease in the anti-
oxidant capacity; the mechanisms underlying this
decrease, however, are not well established [2].
In the present study, we propose a score for oxidative
stress (SOS) based on the analysis of several biomarkers.
Also, we determined the laboratory reference ranges of
the SOS parameters in an ostensibly-healthy human
population. These markers in the SOS were: glutathione
S-transferase (GST), superoxide dismutase (SOD), cata-
lase (CAT), glutathione peroxidase (GPx), glutathione
reductase (GR), reduced and oxidized glutathione (GSH,
GSSG), thiobarbituric acid reactive substances (TBARS)
and hemolysis test (HT). The SOS was applied not only
in healthy control individuals but also in patients with
CRI.
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T h ea n a l y s e sw e r ec o n d u c t e di nt h r e eg r o u p so fi n d i v i -
duals: Group C1: healthy controls (n = 164) recruited
from among the staff of our School of Medicine (age:
48.4 ± 14.5 years; 52 males and 112 females). The indivi-
duals in the C1 group were not on any prescribed medi-
cations (including anti-oxidants), no subject was an
active smoker, the individuals did not participate in regu-
lar intense exercise, and all had moderate exposure to the
sun; Group CRI: patients with uremia pre-dialysis (n =
63) were recruited from the Joan XXIII University Hospi-
tal, Tarragona (age: 62.1 ± 14.3 years; 33 males and 30
females). The CRI group comprised a variety of disease
etiologies, and with creatinine clearance between 7.7 and
35.8 ml/min [see Additional file 1 - Table S1 for general
characteristics of CRI patients]; Group C2: healthy con-
trol subjects (n = 63) composed of individuals in the C1
group but age- and gender-matched for those in the CRI
group. All participants gave fully informed consent to
participation in the study and ethical approval was
obtained from the Ethical Committee for Clinical Investi-
gation (Sant Joan University Hospital, Reus).
Blood was obtained by venepuncture and collected in
lithium-heparin (Li-Hep) as well as EDTA tubes.
Li-Hep sample
Hematocrit and hemoglobin values were obtained using
whole blood. Erythrocytes were preserved at 20°C for
subsequent batched GST activity and HT analysis. To
determine erythrocyte and plasma GSH and GSSG, and
erythrocyte TBARS, samples were deproteinized with
cold 70% trichloroacetic acid (TCA) (final concentration
10%) and centrifuged. The TCA acts as a preservative by
maintaining the sample in an acid medium and, as such,
preempting auto-oxidation. Aliquots of the supernatant
were stored at -20°C for subsequent batched analyses.
EDTA sample
Erythrocytes were stored at -20°C for subsequent batched
analysis of SOD, GPx, GR and CAT. Aliquots of plasma
were stored at -20°C for subsequent TBARS measurement.
GST activity was calculated by the Habig et al method
[3]. We determined GST activity (T-GST) and the
thermo-stable GST fraction (TS-GST). The TS-GST
fraction was also expressed as the % of T-GST, and
termed “residual GST” (%TS-GST). 1-chloro-2,4-dinitro-
benzene (CDNB) was used as substrate for GST.
SOD enzyme activity was measured by the Misra and
Fridovich method [4] based on the auto-oxidation of
epinephrine.
CAT activity was determined by the Cohen et al
method [5]. The rate of hydrogen peroxide breakdown
was monitored.
GR and GPx activities were determined by the
Wheeler et al method [6] which monitors the rate at
which NADP
+ or NADPH is converted.
GSH and GSSG were determined by fluorimetry using
the Hissin and Hilf method using o-phthaldialdehyde
(OPT) as the fluorescent reagent [7] and, from which,
the GSSG/GSH ratio was calculated.
TBARS were determined by the Buege and Aust
method but using fluorescence [8,9]. Lipid peroxidation
was measured as malondialdeyde (MDA) equivalents
using trichloroacetic acid, thiobarbituric acid and hydro-
gen chloride.
The hemolysis test was performed according to the
Farrell et al method [10] using hydrogen peroxide as
hemolytic agent in washed erythrocytes.
To obtain the overall SOS, each parameter received a
numerical value (zero, -1 or +1). The laboratory refer-
ence ranges were obtained from Group C1. Results
within the laboratory reference ranges were assigned
zero points (0); results above or below the laboratory
reference range, and indicating OS, were assigned one
positive point (+1). Results indicating anti-oxidant status
(AS) were assigned one negative point (-1) (Table 1).
The data were processed with the SPSS statistical
package. The 2.5
th and 97.5
th percentiles were obtained
for all biomarkers in the healthy control population
Table 1 Scoring criteria for each biomarker to derive the
score of oxidative stress (SOS)
Biomarkers Value > ULN Value < LLN
Antioxidant enzymes
T-GST -1 +1
TS-GST -1 +1
%TS-GST -1 +1
SOD - 1 +1
CAT -1 +1
GR -1 +1
GPx -1 +1
GSH, GSSH, GSSG/GSH
GSH erythrocytes -1 +1
GSSG erythrocytes +1 -1
GSSG/GSH erythrocytes +1 -1
GSH plasma -1 +1
GSSG plasma +1 -1
GSSG/GSH plasma +1 -1
Lipid peroxidation products
TBARS erythrocytes +1 -1
TBARS plasma +1 -1
Oxidisability measurements
HT +1 -1
-1: antioxidant status; +1: oxidative stress; 0: antioxidant pro-oxidant
equilibrium; ULN: upper limit of normal; LLN: lower limit of normal
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mality” for the patient population. Relationships between
the variables were evaluated with the Pearson linear cor-
relation coefficient (r). Multiple linear regression analy-
sis was used to identify predictors of the model. Results
from CRI patients and those from C2 healthy controls
were compared using the Student t-test, or the Mann-
Whitney test.
Discriminant analysis was used to statistically evaluate
the variables that would distinguish healthy individuals
from those with CRI, using the variables of oxidative stress.
The results of the discriminant score were compared with
the SOS. Statistical significance was set at p < 0.05.
Results
Table 2 summarizes the values of OS biomarkers in ery-
throcytes and plasma in healthy control group C1. These
are the values we used as the reference limits to calculate
SOS. The C1 control group comprises individuals who
have not been exposed to the main exogenous factors of
ROS production. As such, the values of biomarkers could
be used as reference for other OS studies.
Table 3 summarizes the significant Pearson correla-
tions between biomarkers. There were several
correlations:
#1: between peroxidation products and antioxidant
enzymes [i.e. erythrocyte TBARS and SOD (r = -0.292;
p < 0.001), erythrocyte GSSG and SOD (r = -0.201;
p = 0.01), erythrocyte GSSG and GR (r = -0.189;
p = 0.021) and erythrocyte GSSG and GPx (r = 0.185;
p = 0.033)].
#2: between oxidizability and antioxidant enzymes
[i.e. HT and GPx (r = 0.182; p = 0.036)].
#3: between lipid and peptide peroxidation products.
#4: between antioxidant enzymes and low-molecular-
weight antioxidants [i.e. T-GST and erythrocyte GSH
(r = 0.205; p = 0.009)].
#5: correlations within the same category [i.e. erythro-
cyte and plasma TBARS (r = 0.358; p < 0.001), erythro-
cyte GSSG and GSSG/GSH (r = 0.866, p < 0.001) and
TS-GST and %TS-GST (r = 0.805, p < 0.001)].
The larger number of statistically significant correla-
tions indicates that assessing OS using a single biomar-
ker is unacceptable. Based on previous studies [11], and
the current data, we believe that joint evaluation of sev-
eral biomarkers would provide more realistic, and com-
prehensive, data on antioxidant versus pro-oxidant
balance.
Some predictor biomarkers were found by multiple
linear regression analysis (R
2). Most biomarkers can be
predicted by other, interrelated, biomarkers. Those with
the highest values of R
2 a r es h o w ni nT a b l e4 .S o m e
studies have suggested that the ratio of SOD/(GPx +
CAT) activities in erythrocytes, rather than the absolute
amounts of individual antioxidant enzymes, is indicative
of oxidative imbalance [12]. Other studies propose a
mathematical model of glutathione metabolism as a tool
to investigate the influence of oxidative stress on some
pathologies [13].
The weighting of each biomarker in the scoring sys-
tem proposed in this article (Table 1) was derived from
data from the literature and from the statistical analyses
of the current results from group C1.
The values of the antioxidant enzymes GST, SOD,
CAT, GPx and GR were scored in a similar manner.
High values of antioxidant enzymes therefore indicate
antioxidative status (AS score: -1) and low values indi-
cate oxidative stress (OS score: +1). An increase in
TBARS content was taken as indicative of oxidative
damage. Therefore, TBARS values above the upper limit
of normal (ULN) were assigned +1 point (OS) in plasma
as well as erythrocytes because of the positive correla-
tion between them.
The GSSG/GSH ratio is considered the redox value
that best determines the antioxidant capacity of cells
[ 1 4 ] ,a n da n yi n c r e a s es u g g e s t sas t r o n gp r o - o x i d a n t
effect [15]. In the SOS, high values of both the GSSG
and the GSSG/GSH ratio indicate OS (score: +1) and
low values indicate AS (score: -1). GSH is an important
low-molecular-weight antioxidant and, as such, high
v a l u e sw o u l di n d i c a t eA S( s c o r e- 1 )a n dl o wv a l u e s
would indicate OS (score +1).
Table 2 Oxidative stress biomarkers in the C1 group
(healthy controls)
Biomarkers of C1 Mean ± SD LLN-ULN
Erythrocytes
T-GST (μmol/min/g Hb) 1.60 ± 0.48 (163) 0.79-2.63 (163)
TS-GST (μmol/min/g Hb) 0.38 ± 0.24 (146) 0.08-1.00 (146)
%TS-GST 24.33 ± 14.12 (145) 6.44-63.24 (145)
GSH (μmol/g Hb) 5.11 ± 1.48 (164) 2.79-8.51 (164)
GSSG (μmol/g Hb) 0.79 ± 0.42 (164) 0.21-1.98 (164)
GSSG/GSH 0.17 ± 0.11 (164) 0.03-0.39 (164)
TBARS (nmol/g Hb) 4.73 ± 3.01 (158) 1.20-12.92 (158)
CAT (mmol/min/g Hb) 222 ± 38 (149) 144-295 (149)
GPx (μmol/min/g Hb) 28.25 ± 8.10 (133) 13.71-49.74 (133)
GR (μmol/min/g Hb) 3.48 ± 1.38 (149) 1.55-7.57 (149)
SOD (U/g Hb) 1763 ± 535 (155) 914-2806 (155)
HT (%) 12.19 ± 4.83 (150) 5.06-21.57 (150)
Plasma
GSH (nmol/ml) 22.48 ± 12.01 (164) 4.47-50.79 (164)
GSSG (nmol/ml) 24.58 ± 7.39 (164) 11.94-40.09 (164)
GSSG/GSH 1.60 ± 1.32 (164) 0.28-5.27 (164)
TBARS (nmol/ml) 1.86 ± 1.11 (163) 0.30-4.76 (163)
Reference ranges and means ± SD (n) for the biomarkers of oxidative stress
where “n” is the number of subjects per group. The lower limit of normal
(LLN) and the upper limit of normal (ULN) are the 2.5th and 97.5th
percentiles, respectively.
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been criticized [16,17]. Further, the values in plasma can
be modified in the course of obtaining the sample i.e. oxi-
dation of the molecule can occur as a result of the action
of the endogenous enzyme present in plasma. For this
reason, although the necessary conservatory precautions
were taken to minimize this occurrence, the biomarkers
GSH, GSSG and TBARS in plasma may be eliminated
from the group of biomarkers comprising the SOS.
HT is an indicator of the susceptibility of erythrocytes
to OS. A high HT was therefore considered to be indi-
cative of OS (score: +1) and low levels to be indicative
of AS (score: -1).
Finally, the new multi-biomarker score (SOS) was
obtained using a simple mathematical formula (SUM func-
tion) linked to a Microsoft Excel® spreadsheet. The SOS
values in the C1 group were normally distributed around
the mean which, by definition, was 0 points (Figure 1).
Table 3 Significant Pearson correlation coefficients between oxidative stress biomarkers in the C1 group
Biomarkers PC Biomarkers PC Biomarkers PC
TBARS p - TBARS e 0.358 TBARS e -GSH p 0.184 T-GST -TBARS p -0.186
TBARS p - GSH e -0.292 TBARS e -GSSG/GSH p -0.227 T-GST -GSH e 0.205
TBARS p - GSSG e -0.218 TBARS e -T-GST -0.188 T-GST -GSH p -0.157
TBARS p - GSSG/GSH p -0.176 TBARS e -TS-GST -0.173 T-GST -GSSG/GSH p 0.219
TBARS p - GR 0.367 TBARS e -SOD -0.292 T-GST -TS-GST 0.446
GSSG e - GSSG/GSH e 0.866 GSSG/GSH e -GSH e -0.45 TS-GST -TBARS p 0.224
GSSG e - T-GST 0.213 GSSG/GSH e -%TS-GST -0.235 TS-GST -GSSG e -0.189
GSSG e - SOD -0.206 GSSG/GSH e -SOD -0.161 TS-GST -%TS-GST 0.805
GSSG e - CAT -0.194 GSSG/GSH e -GR -0.161 TS-GST -GR 0.303
GSSG e - GR -0.189
GSH p - GSSG p -0.202 GSSG p -GSSG e 0,390 %TS-GST -TBARS p 0.342
GSH p - GSSG/GSH p -0.725 GSSG p -GSSG/GSH e 0,373 %TS-GST -GSSG e -0.325
GSH p - %TS-GST -0.167 GSSG p -GSSG/GSH p 0,379 %TS-GST -GR 0.341
GSH p - GR -0.195 GSSG p -SOD -0,197 %TS-GST -GPx -0.299
CAT - TBARS p 0.205 GPx -TBARS p -0.377
CAT - GSH e 0.193 GPx -GSH e 0.196
CAT - GSSG/GSH e -0.268 GPx -GSSG e 0.185
CAT - GR 0.218 GPx -HT 0.182
CAT - HT -0.258
Pearson correlation (PC) for the biomarkers of oxidative stress; “e” and “p” are measurements performed in erythrocytes and plasma, respectively
Table 4 Predictor variables identified by multiple linear regression analysis in the C1 group data
Biomarker Biomarker Biomarker
Dependent Predictor R
2 Dependent Predictor R
2 Dependent Predictor R
2
TS-GST %TS-GST 0.927 TBARS p %TS-GST 0.538 GSH e GSSG/GSHe 0.716
T-GST TBARS e GSSG e
TBARS p GR TBARS p
GSH p GPx GSSG p
GSH e
%TS-GST TS-GST 0.913 TBARS e TBARS p 0.261 GSSG/GSH p GSH p 0.681
T-GST TS-GST GSSG p
TBARS p GSSG/GSH e TBARS e
GSH p SOD
T-GST TS-GST 0.775 GSH p GSSG/GSH p 0.624
%TS-GST GR
GSH p GSSG e
GPx TBARS p 0.223 GR TBARS p 0.248 GSSG p GSSG/GSH p 0.382
CAT GPx GSSG e
HT TBARS e
Correlation between the observed and predicted values of the dependent variable, multiple correlation coefficient (R2) for the biomarkers of oxidative stress.
Multiple linear regression analysis using the “stepwise” procedure; “e” and “p” are measurements performed in erythrocytes and plasma, respectively
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markers between the C2 and the CRI groups.
Changes in the enzymatic antioxidant systems (GST,
GR), non-enzymatic antioxidant system (GSSG) and oxi-
dizability (HT) indicate OS in CRI patients. Erythrocyte
GSSG and GSSG/GSH were higher in CRI patients than
in C2 subjects (1.52 ± 0.77 vs. 0.80 ± 0.41, p <0 . 0 0 1 ;
0.42 ± 0.49 vs. 0.17 ± 0.11, p < 0.001), as were T-GST
(2.55 ± 0.89 vs. 1.68 ± 0.45, p < 0.001) and GR (4.39 ±
2.22 vs. 3.60 ± 1.47, p=0.001) enzymes. HT was also
significantly higher in CRI patients (14.44 ± 5.48 vs.
11.08 ± 4.41, p < 0.001). Previous studies have shown
higher GSSG levels in patients with uremia, together
with increased activities of GST and GR in erythrocytes
[14]. Also, there have been studies in which the GPx
activity in patients was lower than in healthy group,
although the decrease becomes more marked when the
G P xa c t i v i t yi sm e a s u r e di np l a s m at h a ni nr e db l o o d
cells [18,19]. In our case, the levels of GPx were mea-
sured in erythrocytes and the results are similar in both
Figure 1 Score of oxidative stress in a healthy group of
individuals. Frequency distribution of score of oxidative stress (SOS)
in the C1 control group (bars). The normal distribution curve is
superimposed on the histogram.
Figure 2 Oxidative stress biomarkers in patients with uremia. Biomarkers of oxidative stress and score of oxidative stress (SOS) in the C2
control group, and in the pre-dialysis patients with uremia (CRI group) (mean ± SD). * p < 0.05 for CRI versus C2.
Romeu et al. BMC Research Notes 2010, 3:20
http://www.biomedcentral.com/1756-0500/3/20
Page 5 of 7groups. In our study, if each biomarker is considered
individually, there appears to be no clear distinction
between C2 and CRI individuals, especially in relation to
some of the biomarkers such as TBARS, SOD, CAT [see
Additional file 2 - Table S2 for oxidative stress biomar-
kers in the C2 and CRI groups]. Nevertheless, SOS was
significantly higher in CRI patients (0.62 ± 1.41 vs. -0.05
±0 . 9 4 ,p < 0.001) which suggests that SOS could be a
useful multi-biomarker of clinical OS. A reliable mea-
sure of the global anti-oxidant capacity in CRI patients
would be useful but, unlike in other diseases, the deter-
mination of a total antioxidant potential (i.e. by measur-
ing the ability of a biological fluid to resist oxidation)
failed to act as a reliable parameter [20].
We used the discriminant analysis to evaluate the
“manual” scoring [21]. The discriminant statistical ana-
lyses derived an equation that generates a score for each
individual. The discriminant score is used to enhance
the separation between the individuals in the C2 and
CRI groups.
The variables that the statistical discriminant test used
to construct the equation, and to assign a score to each
individual, were: T-GST, TS-GST, erythrocyte and
plasma GSSG/GSH and HT.
A total of 92.1% of individuals in the C2 group and
82.5% in the CRI group were classified correctly using
the discriminant score.
SOS correlated positively with the discriminant score (R
= 0.243, p = 0.006). As such, the SOS, as well as the discri-
minant analysis score, provides quantitative measures of
OS. However, discriminant analysis has some disadvan-
tages, the Fisher discriminant function derived from the
two groups in the current study may not apply to other
groups of patients with different pathologies (a group of
patients with respiratory disease, for example).
In conclusion, the most important mechanism that
causes disequilibrium between oxidants and antioxidants
in patients with CRI is, essentially, glutathione oxidation,
and the related enzymes. Further, the susceptibility of
the erythrocyte membranes to oxidation is increased in
these patients.
Interestingly, when we used the SOS system we noted
increased OS in the CRI population, even in those who
were not on dialysis. Therefore, our multi-biomarker
could provide a reliable new biochemical parameter
(SOS) to evaluate the clinical status of these patients.
Additional file 1: General characteristics of CRI patients (n = 63).
Distribution of clinical and biochemical variables
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-0500-3-20-
S1.PDF]
Additional file 2: Oxidative stress biomarkers in the C2 and CRI
groups. Means ± SD for the biomarkers of oxidative stress in the C2
control group, and in the pre-dialysis patients with uremia (CRI group),
where “n” is the number of subjects per group. * p < 0.05 for CRI versus
C2
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-0500-3-20-
S2.PDF]
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